What is the CGON stock price prediction for next 2 weeks?

According to our price prediction algorithm,CG Oncology, Inc. Common stock (CGON) price will be around $64.82 in the next 2 weeks. This means it will increase by 18.53081002011337 from the last closing price. This prediction may vary from other time period filters for CGON stock.

What can be the highest Possible price of CGON stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CGON can achieve the highest price of $68.02 which is 24.374460826686494 higher than last closing price. This prediction may vary from other time period filters for CGON stock.

What can be the lowest Possible price of CGON stock in next 2 weeks?

As per the forecast and algorithmic analysis, CGON stock price can be as low as $61.42 which is 12.31265004306777 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for CGON stock.

Will CGON stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that CGON stock will gain18.53081002011337 in the next 2 weeks. This prediction may vary from other time period filters for CGON stock.

What is CGON stock last closing price?

Last closing price of CGON stock was $54.69.

What is CGON stock price prediction?

CGON stock price prediction means predicting the future closing prices of CGON stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CGON stock in a certain time period.

How we predict CGON stock future prices?

If you are searching for CGON stock forecast, analysis or price prediction, then you might be wondering what CG Oncology, Inc. Common stock (CGON) will do in the future. Our CGON price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CGON price prediction will likely answer most of your questions.

How frequent we update CGON stock predictions?

We are updating the forecasts for the CGON stock on daily basis.

Is using ML forecasting for CGON stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CGON stock same for all the time periods?

No, the prediction for CGON stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

CG Oncology, Inc. Common stock Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$54.6928.83%Since 2 Weeks

Predicted Price$64.8218.53%For 2 Weeks

Upper Predicted Price$68.0224.37%For 2 Weeks

Lower Predicted Price$61.4212.31%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CGON will rise by +18.53% over the next 2 Weeks and hit $64.82 by Tuesday, February 3, 2026. In that time frame, CGON's share price is expected to range between $61.42 and $68.02.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 3, 2026	61.42	64.82	68.02
Feb 2, 2026	62.01	65.04	68.43
Jan 30, 2026	60.82	64.13	67.20
Jan 29, 2026	58.89	61.92	64.87
Jan 28, 2026	58.41	61.51	64.40
Jan 27, 2026	56.75	59.77	63.02
Jan 26, 2026	56.86	59.98	62.74
Jan 23, 2026	56.00	59.08	62.11
Jan 22, 2026	53.81	56.86	59.92
Jan 21, 2026	53.43	56.45	59.42

CGON shares rose +4.41% in Wednesday, January 21, 2026's trading session, rising from a previous close of $54.69 to move at $57.10. The stock demonstrated notable intraday movement (see CGON's key stats for a full breakdown), fluctuating between $53.89 and $57.85, a +7.36% trading range. While recent weeks have seen some volatility, CGON has managed to secure a +41.44% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 922.04K shares changing hands, 72.81K fewer than the previous session. This amounted to $52.65M in total market activity.

Will CGON Continue Its Upward Trend?

According to analyst ratings and projections for CGON, CG Oncology, Inc. Common stock shares are anticipated to increase by +16.05%, potentially reaching $68.02 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for CGON. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the CGON stock forecast, now is a good time to buy CGON stock because its current trading price is -11.92% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CGON covering social and institutional perspectives.

CGON Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CGON's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 70.73% to 77.04%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 64.10%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 60.03%, points to growing bullish momentum over the long term. Insights into CGON's shareholder base show how institutional investors are positioning themselves during these momentum shifts

CG Oncology Common stock Short-Term Forecasts

CGON Forecast For Next 5 Days

Our algorithm anticipates CG Oncology Common stock (CGON) stock could hit $54.21 by Jan 28, 2026. This represents a -5.07% rise from today's price, following a +1.81% change over the past five days.

CGON Forecast For Next 30 Days

Based on analysis of market trends, the outlook for CG Oncology, Inc. Common stock (CGON) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $55.45, which would mean a -2.89% decrease from the current price of $57.10. Projections for this period range from a high of $65.33 to a low of $48.11.

CGON Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for CG Oncology Common stock's price over the next three months point to a drop. CGON stock is expected to peak at $59.13 on Mar 18, 2026 after potentially dipping to $48.21 on Jan 23, 2026. On average, CGON is likely to trade around $54.12 in the coming 90 days.

CG Oncology Common stock Stock Forecast 2025

Based on our predictive models, CG Oncology Common stock (CGON) is expected to trade between $46.86 and $63.99 throughout 2026. This would result in an average price of $53.63, potentially offering investors a -6.08% return from current levels.

CG Oncology, Inc. Common stock Monthly Forecast 2026–2027

January 2026

According to our latest forecast models, CG Oncology, Inc. Common stock (CGON) is positioned to show a strong performance in January 2026. The price is predicted to move between $48.21 and $54.36, settling at an average of $51.35. This could translate to a -10.01% loss.

February 2026

Based on current market signals, CG Oncology, Inc. Common stock is projected to trend february 2026. We forecast a trading range from $48.27 to $58.25, with a likely average price of $52.70. Investors could expect a potential return of -7.64%.

March 2026

Our predictive algorithms indicate CG Oncology, Inc. Common stock stock may see a shift in March 2026. The expected range spans $52.13–$59.13, with an average target of $55.76. This represents a cautious outlook and a possible loss of -2.28%.

April 2026

Analyzing established trends, CG Oncology, Inc. Common stock looks set to move in April 2026. Projections place the stock between $51.24 and $58.84, averaging around $55.37. This suggests a -2.96% loss from current levels.

May 2026

Market indicators suggest CG Oncology, Inc. Common stock could experience notable changes during May 2026. Prices could fluctuate within $48.97 to $58.31, with a midpoint forecast of $54.21. The stock might deliver a -4.99% loss.

June 2026

Forecasting for June 2026, models estimate that CG Oncology, Inc. Common stock may undergo key fluctuations. If trends hold, the stock might trade between $47.49 and $57.70, averaging $52.30. This signals a cautious trajectory with potential returns around -8.34%.

July 2026

According to our latest forecast models, CG Oncology, Inc. Common stock (CGON) is positioned to show a strong performance in July 2026. The price is predicted to move between $47.77 and $57.99, settling at an average of $52.60. This could translate to a -7.82% loss.

August 2026

Based on current market signals, CG Oncology, Inc. Common stock is projected to trend august 2026. We forecast a trading range from $51.32 to $58.42, with a likely average price of $55.07. Investors could expect a potential return of -3.49%.

September 2026

Our predictive algorithms indicate CG Oncology, Inc. Common stock stock may see a shift in September 2026. The expected range spans $51.14–$58.03, with an average target of $54.91. This represents a cautious outlook and a possible loss of -3.77%.

October 2026

Analyzing established trends, CG Oncology, Inc. Common stock looks set to move in October 2026. Projections place the stock between $48.11 and $63.12, averaging around $53.46. This suggests a -6.31% loss from current levels.

November 2026

Market indicators suggest CG Oncology, Inc. Common stock could experience notable changes during November 2026. Prices could fluctuate within $46.86 to $63.99, with a midpoint forecast of $52.15. The stock might deliver a -8.60% loss.

December 2026

Forecasting for December 2026, models estimate that CG Oncology, Inc. Common stock may undergo key fluctuations. If trends hold, the stock might trade between $47.10 and $57.54, averaging $52.41. This signals a cautious trajectory with potential returns around -8.15%.

January 2027

According to our latest forecast models, CG Oncology, Inc. Common stock (CGON) is positioned to show a strong performance in January 2027. The price is predicted to move between $52.02 and $57.92, settling at an average of $54.81. This could translate to a -3.94% loss.

CGON's history of dividends and stock splits also plays a role in long-term investor confidence.